Samir N Khleif

Samir N Khleif

UNVERIFIED PROFILE

Are you Samir N Khleif?   Register this Author

Register author
Samir N Khleif

Samir N Khleif

Publications by authors named "Samir N Khleif"

Are you Samir N Khleif?   Register this Author

52Publications

1252Reads

19Profile Views

Free Lung Cancer Screening Trends Toward a Twofold Increase in Lung Cancer Prevalence in the Underserved Southeastern United States.

South Med J 2017 03;110(3):188-194

From the Department of Surgery, the Department of Radiology and Imaging, the Department of Medicine/Division of Pulmonary Critical Care, the Department of Medicine/Division of Hematology/Oncology, and the Georgia Cancer Center, Augusta University, Augusta.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14423/SMJ.0000000000000619DOI Listing
March 2017

Programmed death-1 & its ligands: promising targets for cancer immunotherapy.

Immunotherapy 2015 7;7(7):777-92. Epub 2015 Aug 7.

Georgia Regents University Cancer Center, Augusta, GA 30912, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.15.49DOI Listing
June 2016

Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed.

Cancer Immunol Res 2016 May 1;4(5):377-82. Epub 2016 May 1.

Georgia Cancer Center, Augusta University (Previously Georgia Regents University), Augusta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0048DOI Listing
May 2016

Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells.

Cancer Immunol Res 2016 Apr 15;4(4):354-65. Epub 2016 Feb 15.

Cancer Vaccine Section, Vaccine Branch, NCI, Center for Cancer Research, NIH, Bethesda, Maryland. Georgia Cancer Center, Augusta University (previously Georgia Regents University), Augusta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884020PMC
April 2016

Preamble to the 2015 SITC immunotherapy biomarkers taskforce.

J Immunother Cancer 2015 24;3. Epub 2015 Mar 24.

Sidra Medical and Research Center, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0052-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371796PMC
March 2015

Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide.

PLoS One 2014 27;9(1):e86306. Epub 2014 Jan 27.

Vaccine Branch, National Cancer Institute, Bethesda, Maryland, United States of America ; Cancer Center, Georgia Regent University, Augusta, Georgia, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086306PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903525PMC
November 2014

Is the "3+3" dose-escalation phase I clinical trial design suitable for therapeutic cancer vaccine development? A recommendation for alternative design.

Clin Cancer Res 2014 Sep 18;20(18):4758-67. Epub 2014 Jul 18.

Vaccine Branch, National Cancer Institute, Bethesda, Maryland. Georgia Health Sciences Cancer Center, Augusta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167476PMC
September 2014

Ovarian cancer from an immune perspective.

Radiat Res 2014 Aug 18;182(2):239-51. Epub 2014 Jul 18.

a  Georgia Regents University Cancer Center, Augusta, Georgia; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1667/RR13741.1DOI Listing
August 2014

The regulatory landscape for actively personalized cancer immunotherapies.

Nat Biotechnol 2013 Oct;31(10):880-2

1] TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH, Mainz, Germany. [2] Ribological GmbH, Mainz, Germany. [3].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt.2708DOI Listing
October 2013

B7-DC-Ig enhances vaccine effect by a novel mechanism dependent on PD-1 expression level on T cell subsets.

J Immunol 2012 Sep 25;189(5):2338-47. Epub 2012 Jul 25.

Cancer Vaccine Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1103085
Publisher Site
http://dx.doi.org/10.4049/jimmunol.1103085DOI Listing
September 2012

Defining the critical hurdles in cancer immunotherapy.

Authors:
Bernard A Fox Dolores J Schendel Lisa H Butterfield Steinar Aamdal James P Allison Paolo Antonio Ascierto Michael B Atkins Jirina Bartunkova Lothar Bergmann Neil Berinstein Cristina C Bonorino Ernest Borden Jonathan L Bramson Cedrik M Britten Xuetao Cao William E Carson Alfred E Chang Dainius Characiejus A Raja Choudhury George Coukos Tanja de Gruijl Robert O Dillman Harry Dolstra Glenn Dranoff Lindy G Durrant James H Finke Jerome Galon Jared A Gollob Cécile Gouttefangeas Fabio Grizzi Michele Guida Leif Håkansson Kristen Hege Ronald B Herberman F Stephen Hodi Axel Hoos Christoph Huber Patrick Hwu Kohzoh Imai Elizabeth M Jaffee Sylvia Janetzki Carl H June Pawel Kalinski Howard L Kaufman Koji Kawakami Yutaka Kawakami Ulrich Keilholtz Samir N Khleif Rolf Kiessling Beatrix Kotlan Guido Kroemer Rejean Lapointe Hyam I Levitsky Michael T Lotze Cristina Maccalli Michele Maio Jens-Peter Marschner Michael J Mastrangelo Giuseppe Masucci Ignacio Melero Cornelius Melief William J Murphy Brad Nelson Andrea Nicolini Michael I Nishimura Kunle Odunsi Pamela S Ohashi Jill O'Donnell-Tormey Lloyd J Old Christian Ottensmeier Michael Papamichail Giorgio Parmiani Graham Pawelec Enrico Proietti Shukui Qin Robert Rees Antoni Ribas Ruggero Ridolfi Gerd Ritter Licia Rivoltini Pedro J Romero Mohamed L Salem Rik J Scheper Barbara Seliger Padmanee Sharma Hiroshi Shiku Harpreet Singh-Jasuja Wenru Song Per Thor Straten Hideaki Tahara Zhigang Tian Sjoerd H van Der Burg Paul von Hoegen Ena Wang Marij Jp Welters Hauke Winter Tara Withington Jedd D Wolchok Weihua Xiao Laurence Zitvogel Heinz Zwierzina Francesco M Marincola Thomas F Gajewski Jon M Wigginton Mary L Disis

J Transl Med 2011 Dec 14;9:214. Epub 2011 Dec 14.

Earle A, Chiles Research Institute, Robert W, Franz Research Center, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-9-214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338100PMC
December 2011

Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms.

Eur J Immunol 2011 Oct 17;41(10):2977-86. Epub 2011 Aug 17.

Cancer Vaccine Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201141639DOI Listing
October 2011

Therapeutic vaccines for gastrointestinal cancers.

Gastroenterol Hepatol (N Y) 2011 Aug;7(8):517-64

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264936PMC
August 2011

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.

J Transl Med 2010 Dec 7;8:130. Epub 2010 Dec 7.

Departments of Medicine, Surgery and Immunology, University of Pittsburgh, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-8-130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014892PMC
December 2010

AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development.

Clin Cancer Res 2010 Jul 25;16(13):3299-318. Epub 2010 May 25.

National Cancer Institute, Raritan, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0880DOI Listing
July 2010

HPV as a model for the development of prophylactic and therapeutic cancer vaccines.

Curr Mol Med 2009 Aug;9(6):766-73

Cancer Vaccine Section, National Cancer Institute, NCI-NNMC, Bldg 10, Rm. 5101, Bethesda, MD 20889, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156652409788970625DOI Listing
August 2009

Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers.

Cancer Immunol Immunother 2008 Sep 23;57(9):1413-20. Epub 2008 Feb 23.

Cancer Vaccine Section, Vaccine Branch, NCI, NIH, NNMC, Bldg 8, Room 5101, 8901 Wisconsin Ave, Bethesda, MD 20889, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-008-0477-6
Publisher Site
http://dx.doi.org/10.1007/s00262-008-0477-6DOI Listing
September 2008

Jordan palliative care initiative: a WHO Demonstration Project.

J Pain Symptom Manage 2007 May;33(5):628-33

Cancer Control and Palliative Care, World Health Organization, World Health Organization Collaborating Center for Palliative Cancer Care, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2007.02.032DOI Listing
May 2007

Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice.

Int J Cancer 2006 Jun;118(12):3022-9

Vaccine Branch, NCI, National Naval Medical Center, Bldg 8, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21781DOI Listing
June 2006

Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism.

Cancer 2006 Mar;106(5):1065-77

Cancer Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20889, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21697
Publisher Site
http://dx.doi.org/10.1002/cncr.21697DOI Listing
March 2006

Identification of H-2Db-specific CD8+ T-cell epitopes from mouse VEGFR2 that can inhibit angiogenesis and tumor growth.

J Immunother 2006 Jan-Feb;29(1):32-40

The Vaccine Branch, The Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20889, USA.

View Article

Download full-text PDF

Source
February 2006

Human papillomavirus therapy for the prevention and treatment of cervical cancer.

Authors:
Samir N Khleif

Curr Treat Options Oncol 2003 Apr;4(2):111-9

Center for Cancer Research, National Cancer Institute, National Naval Medical Center, Building 8, Room 4137, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
April 2003